Continuation of immune checkpoint inhibitors for newly developed brain metastasis during immune checkpoint inhibitor treatment for oligoprogressive metastatic renal cell carcinoma

被引：0
|
作者：
Ishihara, Hiroki [1 ]
Fukuda, Hironori [2 ]
Yoshida, Kazuhiko [2 ]
Hashimoto, Yasunobu [3 ]
Kondo, Tsunenori [1 ]
Takagi, Toshio [2 ]
机构：
[1] Tokyo Womens Med Univ, Adachi Med Ctr, Dept Urol, Tokyo, Japan
[2] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan
[3] Saiseikai Kawaguchi Gen Hosp, Dept Urol, Saitama, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2023年 / 30卷 / 02期
关键词：
brain metastases; immunotherapy; ipilimumab; nivolumab; RCC; STEREOTACTIC RADIOTHERAPY; THERAPY;
D O I：
10.1111/iju.15086
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：240 / 242
页数：3
相关论文
共 50 条
  • [21] Treatment of Cutaneous Squamous Cell Carcinoma with Immune Checkpoint Inhibitors in Special Populations
    Bossi, Paolo
    Lorini, Luigi
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2021, 11
  • [22] Suspected immune checkpoint inhibitor-induced pulmonary sarcoid reaction in metastatic renal cell carcinoma
    Purcell, Victoria
    Preti, Beatrice
    Fernandes, Ricardo
    CLINICAL CASE REPORTS, 2022, 10 (07):
  • [23] Checkpoint inhibitors in metastatic papillary renal cell carcinoma
    de Vries-Brilland, M.
    McDermott, D. F.
    Suarez, C.
    Powles, T.
    Gross-Goupil, M.
    Ravaud, A.
    Flippot, R.
    Escudier, B.
    Albiges, L.
    CANCER TREATMENT REVIEWS, 2021, 99
  • [24] Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
    Makrakis, Dimitrios
    Bakaloudi, Dimitra Rafailia
    Talukder, Rafee
    Lin, Genevieve Ihsiu
    Diamantopoulos, Leonidas N.
    Jindal, Tanya
    Vather-Wu, Naomi
    Zakharia, Yousef
    Tripathi, Nishita
    Agarwal, Neeraj
    Dawsey, Scott
    Gupta, Shilpa
    Lu, Eric
    Drakaki, Alexandra
    Liu, Sandy
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Fulgenzi, Claudia -Maria
    Cortellini, Alessio
    Pinato, David
    Barata, Pedro
    Grivas, Petros
    Khaki, Ali Raza
    Koshkin, Vadim S.
    CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 286 - 294
  • [25] Neopterin as a potential prognostic and predictive biomarker in metastatic renal cell carcinoma treated with immune checkpoint inhibitors
    Studentova, Hana
    Hola, Katerina
    Melichar, Bohuslav
    Spisarova, Martina
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (06) : 339 - 345
  • [26] Editorial on immune checkpoint inhibitors in the treatment of hepatocellular carcinoma
    Ruff, Samantha M.
    Pawlik, Timothy M.
    IMMUNOTHERAPY, 2023, 15 (16) : 1323 - 1326
  • [27] Biological Biomarkers of Response and Resistance to Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Masson, Claire
    Thouvenin, Jonathan
    Boudier, Philippe
    Maillet, Denis
    Kuchler-Bopp, Sabine
    Barthelemy, Philippe
    Massfelder, Thierry
    CANCERS, 2023, 15 (12)
  • [28] Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell Carcinoma
    Zhang, Yumeng
    Kumar, Premsai
    Adashek, Jacob J.
    Skelton, William P.
    Li, Jiannong
    Vosoughi, Aram
    Chahoud, Jad
    Manley, Brandon J.
    Spiess, Philippe E.
    CELLS, 2022, 11 (16)
  • [29] Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma
    Abou Alaiwi, Sarah
    Xie, Wanling
    Nassar, Amin H.
    Dudani, Shaan
    Martini, Dylan
    Bakouny, Ziad
    Steinharter, John A.
    Nuzzo, Pier Vitale
    Flippot, Ronan
    Martinez-Chanza, Nieves
    Wei, Xiao
    McGregor, Bradley A.
    Kaymakcalan, Marina D.
    Heng, Daniel Y. C.
    Bilen, Mehmet A.
    Choueiri, Toni K.
    Harshman, Lauren C.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [30] Chronic Use of Proton Pump Inhibitors Is Associated With an Increased Risk of Immune Checkpoint Inhibitor Colitis in Renal Cell Carcinoma
    Yin, Jianyi
    Elias, Roy
    Peng, Lan
    Levonyak, Nicholas
    Asokan, Annapoorani
    Christie, Alana
    Kubiliun, Nisa
    Brugarolas, James
    Hammers, Hans J.
    CLINICAL GENITOURINARY CANCER, 2022, 20 (03) : 260 - 269
12345